In 2023, the size of the <b>Arthritis Drug Industry</b> was valued at <b>$45 billion</b> and is anticipated to reach <b>$72 billion</b> by 2033, expanding at a <b>5.0%</b> CAGR between 2024 and 2033. The report encompasses multiple segments and provides an analysis of significant trends and factors impacting the market.
